论文部分内容阅读
目的 探讨中、晚期恶性肿瘤患者血清TSGF的检测价值。方法 对 119例健康人群及 15 4例临床病理确诊为Ⅲ期以上中晚期恶性肿瘤患者进行血清TSGF检测。结果 健康体检组正常值为 5 9.1± 4.68u/ml(<68u/ml为阴性 ,68～ 72u/ml为可疑阳性 ,>72u/ml为阳性 )。中晚期恶性肿瘤测得血清TSGF值为 70 .0± 13 .7u/ml,与健康对照组有显著差异性P <0 .0 1,特异度为 95 .8% ,敏感度为 49.4%。结论 检测中晚期恶性肿瘤患者血清TSGF具有临床应用价值 ,对肝癌、恶性胸腺瘤、肺癌、恶性淋巴瘤敏感度较高 ,有一定的临床应用价值。
Objective To investigate the value of serum TSGF in patients with advanced malignant tumor. Methods Serum TSGF levels were measured in 119 healthy individuals and 15 4 patients with clinically and pathologically diagnosed advanced stage III and advanced stage malignant tumors. Results The normal value of healthy group was 5 9.1 ± 4.68u / ml (<68u / ml was negative, 68 ~ 72u / ml was suspicious positive,> 72u / ml was positive). Serum TSGF value was 70.0 ± 13.7u / ml in advanced malignant tumors, which was significantly different from healthy control group (P <0.01). The specificity was 95.8% and the sensitivity was 49.4%. Conclusion It is of clinical value to detect serum TSGF in patients with advanced malignant tumor, and it is more sensitive to liver cancer, malignant thymoma, lung cancer and malignant lymphoma and has certain clinical value.